Cancer

Surgical Automations Announces Closing of $3.4 Million Oversubscribed Seed Round

DALLAS, Oct. 30, 2025 /PRNewswire/ -- Surgical Automations, a stealth-mode surgical-robotics company leveraging AI and automation to transform gastrointestinal endoscopy,…

4 months ago

Amigo Establishes Medical Advisory Board and Appoints Dr. Jay Shah as Chief Medical Advisor

Stanford Health Care's Chief of Medical Staff to Guide Clinical Strategy for Healthcare AI Platform NEW YORK, Oct. 30, 2025…

4 months ago

Biocare Medical and Hamamatsu Announce Strategic Collaboration to Deliver Integrated Spatial Biology Solutions

SAN FRANCISCO and BRIDGEWATER, N.J., Oct. 30, 2025 /PRNewswire/ -- Biocare Medical, a global leader in immunohistochemistry instrumentation, antibodies and…

4 months ago

Google Cloud to Host Second-Annual Cancer AI Symposium in New York City

Leading organizations, researchers, clinicians, and venture capital firms converge to accelerate AI-driven innovation across the cancer continuum NEW YORK, Oct.…

4 months ago

ChemDiv’s Discovery Platform Enables Differentiated, Reversible Pan‑EGFR Kinase Inhibitors for GFR‑Mutant Lung Cancer

Upgraded design + synthesis engine targets broad mutant coverage with wild‑type EGFR sparing; active collaboration advances toward scale‑up and CMC…

4 months ago

Intensity Therapeutics, Inc. Announces Publication of Clinical Results of INT230-6 for the Treatment of Metastatic or Refractory Cancers in eBioMedicine, a Lancet Discovery Science Journal

The paper features a comprehensive evaluation of data, including disease control rate, overall survival, immune activation, abscopal effects, tumor necrosis,…

4 months ago

Medical Care Technologies Inc. (OTC Pink:MDCE) Ranked #1 on InvestorHub Breakout Boards as Company Expands Across Technology and Collectibles Divisions

MESA, ARIZONA / ACCESS Newswire / October 30, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE), a diversified holding company…

4 months ago

Dogwood Therapeutics to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025

ATLANTA, GA / ACCESS Newswire / October 30, 2025 / Dogwood Therapeutics, Inc. (Nasdaq:DWTX) (the "Company"), a development‐stage biotechnology company…

4 months ago

Moleculin to Highlight its Ongoing Phase 3 Acute Myeloid Leukemia “MIRACLE” Clinical Trial at the 14th Annual Acute Leukemia Meeting

HOUSTON, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company…

4 months ago

Akari Therapeutics Announces Formation of Scientific Advisory Board and Inaugural Appointment of Renowned Medical Oncologist, Sara A. Hurvitz, MD, FACP

Dr. Hurvitz is an international expert in oncology and a recognized clinical research leader with extensive experience leading clinical trials…

4 months ago